Author

A. S. Subramanian

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:E. coli· 2 Approach:experimental assay· 2 Assay:metabolomics· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

A. Eddenden· 2 shared M. Nitz· 2 shared P. L. Howell· 2 shared A. Windemuth· 1 shared C. E. Bear· 1 shared G. Woollard· 1 shared J. M. Troutman· 1 shared L. D. Morayniss· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

A. Eddenden

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The Metabolic Usage and Glycan Destinations of GlcNAz in E. coli

A. Eddenden, M. K. Dooda, Z. A. Morrison, A. S. Subramanian, P. L. Howell, J. M. Troutman, M. Nitz

This paper investigates the metabolic incorporation of GlcNAz into glycans in E. coli, finding it primarily in peptidoglycan with lower levels in PNAG and none in LPS or ECA.

bioRxiv · Aug 17, 2023Biochemistry

Truncation of poly-N-acetylglucosamine (PNAG) polymerization with N-acetylglucosamine analogues

Z. Morrison, A. Eddenden, A. S. Subramanian, P. L. Howell, m. nitz

The paper identifies UDP-GlcNAc analogues that inhibit PNAG polymerization and biofilm formation in E. coli by terminating PNAG chains.

bioRxiv · Oct 13, 2021Biochemistry

Comprehensive mapping of Cystic Fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding site

S. V. Molinski, V. M. Shahani, A. S. Subramanian, S. S. MacKinnon, G. Woollard, M. Laforet, O. Laselva, L. D. Morayniss, C. E. Bear, A. Windemuth

The paper maps CFTR mutations to protein structures and predicts corrector binding sites, identifying mutation clusters and a potential multi-domain binding site for Class I correctors.

bioRxiv · Jan 2, 2018Biochemistry